70 likes | 79 Views
The global market is in its growth phase, and is expected to witness significant growth rate of 63.2% during the forecast period, due to surge in applications of organ-on-chip devices in the healthcare sector and increase in demand for organ-on-chip in drug screening.
E N D
Organ-on-Chip Market predicted to experience noticeable growth in the future! Allied market research Organ-on-Chip Market by Type (Heart-on-chip, Human-on-chip, Intestine-on-chip, Kidney-on-chip, Liver-on-chip, and Lung-on-chip) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Why Allied Market Research? FREQUENTLY ASKED QUESTIONS? INFALLIBLE METHODOLOGY To ensure high-level data integrity, accurate analysis, and impeccable forecasts ANALYST SUPPORT For complete satisfaction CUSTOMIZATION On-demand customization of scope of the report to exactly meet your needs TARGETED MARKET VIEW Targeted market view to provide pertinent information and save time of readers Q1. Who are the leading market players active in the Organ-on-Chip Market? Q2. What are the current trends that will influence the market in the next few years? Q3. What are the driving factors, restraints, and opportunities in the market? Q4. What can be the challenges for the Organ-on-Chip Market in future? Q5. Does the Organ-on-Chip Market company is profiled in the report?
Overview The global organ-on-chip market was valued at $5 million in 2016, and is projected to reach at $170 million by 2023, growing at a CAGR of 63.2% from 2017 to 2023. Heart-on-chip segment is anticipated to witness the highest growth rate during the forecast period. North America was the highest revenue contributor in the global market in 2016, as advancements in cell biology, microfabrication, and microfluidics have led to the development of OOCs. In addition, rise in demand for lung- and kidney-based organ culture devices is expected to boost the market growth. Asia-Pacific is anticipated to witness a significant growth rate during the forecast period, owing to increase in research activities.
Segments In terms of revenue, the global Organ-on-Chip Market is segmented on the basis of Type, and Regions. By Type – The global organ-on-chip market is segmented on the basis of type and geography. Based on type, the market is divided into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lungs-on-chip. Geographically, the organ-on-chip market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2016, the lung-on-chip segment accounted for the highest share in the market, while the heart-on-chip segment is anticipated to witness the highest growth rate from 2017 to 2023, owing to increase in applications of organ-on-chip devices for the cure of several cardiac diseases such as heart failures.
Geography North America dominated the Organ-on-Chip Market. The market growth in North America is primarily a reflection of product innovations and launches resulting from technological advancements. The companies mostly adopted product launch, acquisition, and expansion as their key strategies to keep pace with the changing demands of consumers and strengthen their market position.
Key Market Players • The key players operating in the global Organ-on-Chip Market are • Emulate, Inc. • AxoSim Technologies LLC • CN Bio Innovations • Hurel Corporation • Ascendance Biotechnology, Inc. • Insphero AG • Mimetas B.V. • Nortis Inc. • Organovo Holdings, Inc. • Tara Biosystems
An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans. A comprehensive analysis of factors that drive and restrain the growth of the global is provided. The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2030, in terms of value. Key Findings of the Organ-on-Chip Market: Find out more at the Allied Market Report store https://www.alliedmarketresearch.com/organ-on-chip-market